Clinical Trial: Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population with Stable Mild Plaque Psoriasis, Dry Skin and Pruritus

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06800755) titled 'Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population with Stable Mild Plaque Psoriasis, Dry Skin and Pruritus' on Jan. 24.

Brief Summary: The product RL3020-DP0364 developed by Pierre Fabre Laboratories moisturizes durably and repairs dry or atopic skin, especially in the case of certain dermatoses (atopic dermatitis, ichthyosis, etc ...) and erythema induced by radiotherapy. Its unique formula treats the symptoms of dry skin by creating a protective film that prevents dehydration and helps protect the skin from external aggressions.

Through this study, the efficacy of this medical device...